Integration with Lotus Clinical Research ERG has expanded its service offering to include specialized full-service CRO capabilities.
ERG expands pain capabilities with HD researchHD has partnered with Sponsors and CROs on over 200 clinical trials, focusing on acute postoperative pain.
CNS ratings joins ERG portfolioCNS Ratings is the most established rater training company in the United States, having delivered robust programs internationally to the pharmaceutical industry for over 30 years.
COMMITMENT TO COMMUNITY OUTREACH
The true heroes of clinical research are those who volunteer to advance our understanding of chronic conditions. They are at the heart of everything we do. Partnering with patients, advocates, providers, caregivers and our communities sets the foundation for cutting-edge, scientific discovery.
We know that becoming a part of the communities we serve starts with building trust and meaningful relationships. It goes beyond words and requires action. Evolution Research Group is dedicated to working with national, regional and local advocacy organizations by supporting programs, volunteering, offering research education and support, and ensuring the patient voice is a part of fabric of research studies. We are dedicated to work with healthcare and service providers to ensure research opportunities are an option for all patients. We are seeing countless new therapies showing promising results for those living with chronic conditions, and with the support from patients and their loved ones, we will transform the future of life-changing therapies.
ERG enjoys a proven track record of executing complex inpatient and outpatient clinical research trials in specialized populations and healthy volunteers across all age groups. We begin with industry-leading principal investigators with expertise in more than 50 specific indications. We back them with centralized operations that deliver consistent excellence across our sites. We offer clinical consulting services that provide a reliable resource in countering drug development challenges. Finally, we boast a robust database of more than 215,000 patients complemented by a centralized recruitment and marketing team, local community outreach programs and long-standing referral relationships. The result: Unparalleled support for sponsors and CROs in their quest to address our nation’s greatest unmet medical needs.
Industry-Leading Therapeutic and Early-Phase Expertise
Differentiators
Single Point of Contact
Specialized Patient Recruitment
Complex and Early Phase Trials
Top Investigators
Spotlight
ERG Acquires Richmond Behavioral Associates
Evolution Research Group has acquired Staten Island, NY-based Richmond Behavioral Associates (“RBA”).
Introducing a new ERG logo
As we continue to grow, adding new sites and new capabilities, we have revised our logo. At its core: the people—patients, clinicians, customers—who are at the heart of everything we do.
New FibroScan® equipment at two ERG sites
ERG clinical research sites, Clinical Pharmacology of Miami and Endeavor Clinical Trials, have both installed FibroScan® equipment; they are actively screening patients to identify Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).